Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes

被引：0
|
作者：
Meidong Zhu
Jamie K. Chew
Geoffrey K. Broadhead
Kehui Luo
Nichole Joachim
Thomas Hong
Adil Syed
Andrew A. Chang
机构：
[1] Sydney Institute of Vision Science,Save Sight Institute
[2] The University of Sydney,Statistics Department
[3] Macquarie University,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2015年 / 253卷
关键词：
Ranibizumab; Neovascular age-related macular degeneration (nAMD); As-needed treatment model; Five-year treatment; Exudative age-related macular degeneration; Wet macular degeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1217 / 1225
页数：8
相关论文
共 50 条
  • [21] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [22] Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration
    Kent, Jerrod S.
    Iordanous, Yiannis
    Mao, Alex
    Powell, Anne-Marie
    Kent, Shefalee Shukla
    Sheidow, Tom G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2012, 47 (02): : 159 - 164
  • [23] Ranibizumab for neovascular age-related macular degeneration
    Hernandez-Pastor, Luis Javier
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) : 1805 - 1814
  • [24] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [25] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [26] Comparison of Outcomes When Switching Treatment From Intravitreal Bevacizumab to Ranibizumab in Neovascular Age-Related Macular Degeneration
    Kent, J. S.
    Lordanous, Y.
    Mao, A.
    Shukla, S.
    Sheidow, T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [27] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [28] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
  • [29] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [30] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
12345